ID   YD-17
AC   CVCL_L081
SY   YD17
DR   IARC_TP53; 21620
DR   Wikidata; Q54995385
RX   PubMed=16264262;
CC   Population: Korean.
CC   Doubling time: 29.2 hours (PubMed=16264262).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=16264262).
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
ST   Source(s): PubMed=16264262
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 8
ST   D16S539: 9,12
ST   D18S51: 14,16
ST   D21S11: 28,31
ST   D3S1358: 14,15
ST   D5S818: 12
ST   D7S820: 10,11
ST   D8S1179: 13,15
ST   FGA: 24
ST   Penta D: 9,13
ST   Penta E: 5,12
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 15,16
DI   NCIt; C129857; Gingival squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L082 ! YD-17M
SX   Male
AG   66Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 16
//
RX   PubMed=16264262; DOI=10.1038/emm.2005.48;
RA   Lee E.J., Kim J., Lee S.A., Kim E.-J., Chun Y.-C., Ryu M.H.,
RA   Yook J.-I.;
RT   "Characterization of newly established oral cancer cell lines derived
RT   from six squamous cell carcinoma and two mucoepidermoid carcinoma
RT   cells.";
RL   Exp. Mol. Med. 37:379-390(2005).
//